| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000048553 |
| Receipt No. | R000055307 |
| Scientific Title | Influence on enteral environment and physical condition by the intake of "plant fermentation extract combination food KTH-01" |
| Date of disclosure of the study information | 2022/08/05 |
| Last modified on | 2022/11/30 (Ver. 3) |
| Basic information | ||
| Public title | Influence on enteral environment and physical condition by the intake of "plant fermentation extract combination food KTH-01" | |
| Acronym | Influence on enteral environment and physical condition by the intake of "plant fermentation extract combination food KTH-01" | |
| Scientific Title | Influence on enteral environment and physical condition by the intake of "plant fermentation extract combination food KTH-01" | |
| Scientific Title:Acronym | Influence on enteral environment and physical condition by the intake of "plant fermentation extract combination food KTH-01" | |
| Region |
|
|
| Condition | |||
| Condition | Healthy subjects
|
||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | The subjects take about 0.5g test foods every day in four weeks. We check questionnaire survey of constipation conditions and the enterobacterial flora inspection at baseline and after. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | We observe a bowel movement improvement effect by questionary survey after the intake for four weeks.
In addition, we observe enterobacterial flora and observe the change using 16SrRNA gene analytical method. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | At the baseline and after the examination, we check blood and faeces test and the questionnaire survey of constipation conditions. The subjects takes two capsules(test food 0.5g) per day while 4 weeks. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1).Healthy adult who do not have any serious disease.
2)Gender free. 3)The person who is younger than 75 years old. 4)The tendency to constipation. 5)Did not use any drugs in one month. 6)The person who can maintain an everyday lifestyle. 7)The examination responsibility doctor accepted the participation of the person. |
|||
| Key exclusion criteria | 1)The person who takes medicines every day.
2)The person who has serious diseases (heart disease, liver disease, renal disease, cancer, allergy to food, drug allergy, mental disease). 3)The person who use a laxative, aperient, a supplement, healthy tea regularly and use many it. 4)The person who has food allergy (apple or yam) or drug allergy. 5)Pregnant woman, under the nursing woman. 6)The person who participates in another human clinical study. The one where one month does not pass after another human clinical study participation. 7)The examination responsibility doctor dose not accepted the participation of the person. |
|||
| Target sample size | 12 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kagawa Nutrition University | ||||||
| Division name | KNU Nutrition Clinic | ||||||
| Zip code | 170-8481 | ||||||
| Address | 3-24-3,Komagome,Toshimaku,Tokyo. | ||||||
| TEL | 03-3918-6181 | ||||||
| clinic@eiyo.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kagawa Nutrition University | ||||||
| Division name | KNU Nutrition Clinic | ||||||
| Zip code | 170-8481 | ||||||
| Address | 3-24-3, Komagome,Toshima, Tokyo | ||||||
| TEL | 0339186181 | ||||||
| Homepage URL | |||||||
| clinic@eiyo.ac.jp | |||||||
| Sponsor | |
| Institute | Kagawa Nutrition University
|
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kotohogi Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Kugawa Nutritison University |
| Address | 3-9-21,Chiyoda,Sakado,Saitama |
| Tel | 049-283-2131 |
| clinic@eiyo.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |||||||
| URL related to results and publications | |||||||
| Number of participants that the trial has enrolled | 12 | ||||||
| Results | 1.The stool frequency and the stool output significantly increased.
2.JPAC-QOL;queitionnaire survey of constipation conditions shows that interest/worry, the physical discomfort, the psychic unpleasantness significantly decreased. In addition, the satisfaction significantly rose. 3.By the examination of enterobacterial flora, the share of lactic acid production bacteria rose. |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | |||||||
| Participant flow | |||||||
| Adverse events | |||||||
| Outcome measures | |||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055307 |